{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:47:35Z","timestamp":1773150455052,"version":"3.50.1"},"reference-count":11,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,7,7]],"date-time":"2009-07-07T00:00:00Z","timestamp":1246924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Phytotherapy Research"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Eviprostat is a phytotherapeutic agent that has been used widely for more than 40 years in the treatment of benign prostatic hyperplasia (BPH) in Japan and Germany, and is known to have antioxidant activity. The present study investigated the effect of Eviprostat on the levels of the urinary oxidative stress marker 8\u2010hydroxy\u20102\u2032\u2010deoxyguanosine (8\u2010OHdG) in a rabbit model of surgical partial bladder outlet obstruction (PBOO) and in patients with lower urinary tract symptoms (LUTS) associated with BPH. In the rabbit model, 8\u2010OHdG levels in urine collected after 3 weeks of PBOO were 3.8\u2010fold higher than in the urine of sham\u2010operated rabbits. When twice\u2010daily Eviprostat was administered orally throughout the 3\u2010week PBOO period, the increase in urinary 8\u2010OHdG levels was suppressed by 70%. In the clinical study, nine patients who received Eviprostat for 4 weeks showed 2.5\u2010fold lower urinary 8\u2010OHdG levels than before treatment. During Eviprostat treatment, the total International Prostate Symptom Score (IPSS) decreased from 16.56 \u00b1 2.74 to 13.67 \u00b1 2.30 and the quality of life score from 4.22 \u00b1 0.40 to 3.22 \u00b1 0.46. The findings provide evidence that the antioxidant activity of Eviprostat is responsible for its beneficial effects in the treatment of BPH. Copyright \u00a9 2009 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/ptr.2909","type":"journal-article","created":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T03:02:13Z","timestamp":1247022133000},"page":"301-303","source":"Crossref","is-referenced-by-count":30,"title":["Eviprostat suppresses urinary oxidative stress in a rabbit model of partial bladder outlet obstruction and in patients with benign prostatic hyperplasia"],"prefix":"10.1002","volume":"24","author":[{"given":"Seiji","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Hanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotsugu","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)35405-8"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02575222"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2008.01999.x"},{"issue":"1","key":"e_1_2_1_5_1","first-page":"15","article-title":"Cellular and molecular aspects of bladder hypertrophy","volume":"32","author":"Levin RM","year":"1997","journal-title":"Eur Urol"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/15287399309531806"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.06.015"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2007.04.006"},{"key":"e_1_2_1_9_1","first-page":"299","article-title":"Anti\u2010reactive oxygen species activity and anti\u2010inflammatory activity of Eviprostat, a phytotherapeutic agent for benign prostatic hyperplasia. Relevance to the protective effect on the lower urinary tract dysfunction induced by ischemia\/reperfusion injury","volume":"18","author":"Oka M","year":"2007","journal-title":"Nippon Hainyo Kino Gakkai Shi"},{"key":"e_1_2_1_10_1","first-page":"463","article-title":"Eviprostat, a drug for benign prostatic hyperplasia, ameliorates the urodynamic disturbance in rats with cystitis and with chronic urethral obstruction","volume":"28","author":"Sasaki Y","year":"2000","journal-title":"Jpn Pharmacol Ther"},{"key":"e_1_2_1_11_1","first-page":"674","article-title":"Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia","volume":"11","author":"Song Y","year":"2005","journal-title":"Zhonghua Nan Ke Xue"},{"key":"e_1_2_1_12_1","first-page":"435","article-title":"Assessment of clinical usefulness of Eviprostat for benign prostatic hyperplasia \u2013 comparison of Eviprostat tablet with a formulation containing two\u2010times more active ingredients","volume":"54","author":"Tamaki M","year":"2008","journal-title":"Hinyokika Kiyo"}],"container-title":["Phytotherapy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fptr.2909","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fptr.2909","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ptr.2909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T13:18:43Z","timestamp":1700572723000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ptr.2909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,7]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1002\/ptr.2909"],"URL":"https:\/\/doi.org\/10.1002\/ptr.2909","archive":["Portico"],"relation":{},"ISSN":["0951-418X","1099-1573"],"issn-type":[{"value":"0951-418X","type":"print"},{"value":"1099-1573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,7]]}}}